Review Article

Emerging and re-emerging infectious diseases in Iran


Despite development of preventive and controlling strategies regarding infectious diseases, they are still considered as one of the most significant leading causes of morbidity and mortality, worldwide. Changes in humans’ demographics and behaviors, microbial and ecological alterations, agricultural development, international travels and susceptibility to infectious diseases have resulted in increased reports of emerging infectious diseases (EIDs) and reemerging infectious diseases (RIDs) in various geographical areas.
Because of the various types of geographic properties in Iran, substantial climatic variability, as well as unstable political situations and poor public health conditions in some of neighboring countries, EIDs and RIDs are serious public health problems; among them, zoonotic and drug resistant diseases are the most significant.
Hence, this review provides an overview of the significant bacterial, viral and fungal EIDs and RIDs in Iran regarding their epidemiological aspects.

Desenclos JC, De Valk H. Emergent infectious diseases: importance for public health, epidemiology, promoting factors, and prevention. Med Mal Infect 2005; 35: 49-61.

Barrett R, Kuzawa CW, Mcdade T, Armelagos GJ. Emerging and re-emerging infectious diseases: The third epidemiologic transition. Annu Rev Anthropol 1998;27:247-271.

Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, et al. Global trends in emerging infectious diseases. Nature 2008; 451: 990-993.

Stephen SM. Factors in the Emergence of infectious diseases. Emerg Infect Dis 1995; 1: 7.

Lashley FR. Emerging infectious diseases: vulnerabilities, contributing factors and approaches. Expert Rev Anti Infect Ther 2004; 2: 299-316.

Pherez FM. Factors affecting the emergence and prevalence of vector borne infections (VBI) and the role of vertical transmission (VT). J Vector Borne Dis 2007; 44: 157-163.

Wilder-Smith A, Gubler DJ. Geographic expansion of dengue: the impact of international travel. Med Clin North Am 2008; 92: 1377-1390.

Barnett ED, Walker PF. Role of immigrants and migrants in emerging infectious diseases. Med Clin North Am 2008; 92: 1447-1458.

Chen LH, Wilson ME. The role of the traveler in emerging infections and magnitude of travel. Med Clin North Am 2008; 92: 1409-1432.

Wallace MR, Hale BR, Utz GC, Olson PE, Earhart KC, Thornton SA, et al. Endemic infectious diseases of Afghanistan. Clin Infect Dis 2002; 34: 171-207.

Sultan F, Khan A. Infectious diseases in Pakistan: a clear and present danger. Lancet 2013; 381: 2138-2140.

Pourhossein B, Irani AD, Mostafavi E. Major infectious diseases affecting the Afghan immigrant population of Iran: a systematic review and meta-analysis. Epidemiol Health 2015; 37: e2015002.

Bente DA, Forrester NL, Watts DM, Mcauley AJ, Whitehouse CA, Bray M. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res 2013; 100: 159-189.

Chumakov M, Belyaeva A, Voroshilova M, Butenko A, Shalunova N, Semashko I, et al. Progress in studying the etiology, immunology, and laboratory diagnosis of Crimean hemorrhagic fever in the USSR and Bulgaria. Mater 1968; 15: 100-103.

Saidi S. Viral antibodies in preschool children. Iran J Public Health 1974; 3: 89-91.

Chinikar S, Ghiasi S, Ghalyanchi-Langeroudi A, Goya M, Shirzadi M, Zeinali M, et al. An overview of Crimean-Congo hemorrhagic fever in Iran. Iran J Microbiol 2009; 1: 7-12.

Saidi S, Casals J, Faghih M. Crimean hemorrhagic fever-Congo (CHF-C) virus antibodies in man, and in domestic and small mammals, in Iran. Am J Trop Med Hyg 1975; 24: 353-357.

Sureau P, Klein J, Casals J, Digoutte J, Salaun J, Piazak N, et al. Isolation of Thogoto, Wad Medani, Wanowrie and Crimean-Congo haemorrhagic fever viruses from ticks of domestic animals in Iran. Annales de Virologie 1980; 131: 185-200.

Alavi-Naini R, Moghtaderi A, Koohpayeh HR, Sharifi-Mood B, Naderi M, Metanat M, et al. Crimean-Congo hemorrhagic fever in Southeast of Iran. J Infect 2006; 52: 378-382.

Sadeghi M, Asgharzadeh SA, Bayani M, Alijanpour E, Javaniyan M, Jabbari A. Crimean congo hemorrhagic fever appearance in the north of Iran. Caspian J Intern Med 2013; 4: 617-620.

Ardalan MR, Tubbs RS, Chinikar S, Shoja MM. Crimean-Congo haemorrhagic fever presenting as thrombotic microangiopathy and acute renal failure. Nephrol Dial Transplant 2006; 21: 2304-2307.

Chinikar S, Shayesteh M, Khakifirouz S, Jalali T, Rasi Varaie FS, Rafigh M, et al. Nosocomial infection of Crimean-Congo haemorrhagic fever in eastern Iran: case report. Travel Med Infect Dis 2013; 11: 252-255.

Chinikar S, Ghiasi SM, Moradi M, Goya MM, Shirzadi MR, Zeinali M, et al. Geographical distribution and surveillance of Crimean-Congo hemorrhagic fever in Iran. Vector Borne Zoonotic Dis 2010; 10: 705-708.

Mostafavi E, Pourhossein B, Chinikar S. Clinical symptoms and laboratory findings supporting early diagnosis of Crimean-Congo hemorrhagic fever in Iran. J Med Virol 2014; 86: 1188-1192.

Chinikar S, Ghiasi SM, Naddaf S, Piazak N, Moradi M, Razavi MR, et al. Serological evaluation of Crimean-Congo hemorrhagic fever in humans with high-risk professions living in enzootic regions of Isfahan province of Iran and genetic analysis of circulating strains. Vector Borne Zoonotic Dis 2012; 12: 733-738.

Chinikar S, Moghadam AH, Parizadeh SJ, Moradi M, Bayat N, Zeinali M, et al. Seroepidemiology of Crimean Congo Hemorrhagic Fever in Slaughterhouse Workers in North Eastern Iran. Iran J Public Health 2012; 41: 72-77.

Sharifi-Mood B, Metanat M, Alavi-Naini R. Prevalence of crimean-congo hemorrhagic Fever among high risk human groups. Int J High Risk Behav Addict 2014; 3: e11520.

Hadinia A, Ilami O, Mousavizadeh A, Akbartabar Tori M, Khosravani SA. Seroepidemiology of Crimean-Congo hemorrhagic fever in High Risk Professions in Yasuj. J Mazandaran Univ Med Sci 2012; 22: 45-50.

Chinikar S, Persson SM, Johansson M, Bladh L, Goya M, Houshmand B, et al. Genetic analysis of Crimean-congo hemorrhagic fever virus in Iran. J Med Virol 2004; 73: 404-411.

Chinikar S, Shah-Hosseini N, Bouzari S, Jalali T, Shokrgozar MA, Mostafavi E. New circulating genomic variant of Crimean-Congo hemorrhagic fever virus in Iran. Arch Virol 2013; 158: 1085-1088.

Bokaie S, Mostafavi E, Haghdoost A, Keyvanfar H, Gooya M, Meshkat M, et al. Crimean Congo hemorrhagic fever in northeast of Iran. J Animal Vet Adv 2008; 7: 354-361.

Mahzounieh M, Dincer E, Faraji A, Akin H, Akkutay AZ, Ozkul A. Relationship between Crimean-Congo hemorrhagic fever virus strains circulating in Iran and Turkey: possibilities for transborder transmission. Vector Borne Zoonotic Dis 2012; 12: 782-785.

Chinikar S, Bouzari S, Shokrgozar MA, Mostafavi E, Jalali T, Khakifirouz S, et al. Genetic Diversity of Crimean Congo Hemorrhagic Fever Virus Strains from Iran. Iran J Arthropod Borne Dis 2016; 10: 127-140.

Chinikar S, Ghiasi SM, Moradi M, Goya MM, Reza Shirzadi M, Zeinali M, et al. Phylogenetic analysis in a recent controlled outbreak of Crimean-Congo haemorrhagic fever in the south of Iran, December 2008. Euro Surveill 2010; 15: pii: 19720

Mostafavi E, Chinikar S, Esmaeili S, Amiri FB, Tabrizi AM, Khakifirouz S. Seroepidemiological survey of Crimean-Congo hemorrhagic fever among sheep in Mazandaran province, northern Iran. Vector Borne Zoonotic Dis 2012; 12: 739-742.

Telmadarraiy Z, Ghiasi SM, Moradi M, Vatandoost H, Eshraghian MR, Faghihi F, et al. A survey of Crimean-Congo haemorrhagic fever in livestock and ticks in Ardabil Province, Iran during 2004-2005. Scand J Infect Dis 2010; 42: 137-141.

Champour M, Mohammadi G, Chinikar S, Razmi G, Shah-Hosseini N, Khakifirouz S, et al. Seroepidemiology of Crimean-Congo hemorrhagic fever virus in one-humped camels (Camelus dromedarius) population in northeast of Iran. J Vector Borne Dis 2014; 51: 62.

Mostafavi E, Chinikar S, Moradi M, Bayat N, Meshkat M, Fard MK, et al. A Case Report of Crimean Congo Hemorrhagic Fever in Ostriches in Iran. O Virol J 2013; 7: 81-83.

Tahmasebi F, Ghiasi SM, Mostafavi E, Moradi M, Piazak N, Mozafari A, et al. Molecular epidemiology of Crimean- Congo hemorrhagic fever virus genome isolated from ticks of Hamadan province of Iran. J Vector Borne Dis 2010; 47: 211-216.

Mehravaran A, Moradi M, Telmadarraiy Z, Mostafavi E, Moradi AR, Khakifirouz S, et al. Molecular detection of Crimean-Congo haemorrhagic fever (CCHF) virus in ticks from southeastern Iran. Ticks Tick Borne Dis 2013; 4: 35-38.

Fakoorziba MR, Golmohammadi P, Moradzadeh R, Moemenbellah-Fard MD, Azizi K, Davari B, et al. Reverse transcription PCR-based detection of Crimean-Congo hemorrhagic fever virus isolated from ticks of domestic ruminants in Kurdistan province of Iran. Vector Borne Zoonotic Dis 2012; 12: 794-799.

Telmadarraiy Z, Moradi A, Vatandoost H, Mostafavi E, Oshaghi M, Zahirnia A, et al. Crimean-Congo hemorrhagic fever: a seroepidemiological and molecular survey in Bahar, Hamadan province of Iran. Asian J Anim Vet Adv 2008; 3: 321-327.

Mostafavi E, Chinikar S, Bokaei S, Haghdoost A. Temporal modeling of Crimean-Congo hemorrhagic fever in eastern Iran. Int J Infect Dis 2013; 17: e524-528.

Garmendia AE, Van Kruiningen HJ, French RA. The West Nile virus: its recent emergence in North America. Microbes Infect 2001; 3: 223-229.

Rappole JH, Derrickson SR, Hubalek Z. Migratory birds and spread of West Nile virus in the Western Hemisphere. Emerg Infect Dis 2000; 6: 319-328.

Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ. West Nile virus. Lancet Infect Dis 2002; 2: 519-529.

Lanciotti RS, Ebel GD, Deubel V, Kerst AJ, Murri S, Meyer R, et al. Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology 2002; 298: 96-105.

Naficy K, Saidi S. Serological survey on viral antibodies in Iran. Trop Geogr Med 1970; 22: 183-188.

Fereidouni SR, Ziegler U, Linke S, Niedrig M, Modirrousta H, Hoffmann B, et al. West Nile virus monitoring in migrating and resident water birds in Iran: are common coots the main reservoirs of the virus in wetlands? Vector Borne Zoonotic Dis 2011; 11: 1377-1381.

Sharifi Z, Mahmoodian Shooshtari M, Talebian A. A study of West Nile virus infection in Iranian blood donors. Arch Iran Med 2010; 13: 1-4.

Chinikar S, Javadi A, Ataei B, Shakeri H, Moradi M, Mostafavi E, et al. Detection of West Nile virus genome and specific antibodies in Iranian encephalitis patients. Epidemiol Infect 2012; 140: 1525-1529.

Mehravarana A MM, Telmadarraiy Z, Mostafavid E, Moradie Ar, Khakifirouz S, Shah-Hosseini N, Rasi- Varaie Fs, Jalali T, Hekmat S, Ghiasi Sm, Chinikar S. Molecular detection of Crimean-Congo haemorrhagic fever (CCHF) virus in ticks from southeastern Iran. Ticks Tick Borne Dis 2013; 4: 35-38.

Ahmadnejad F, Otarod V, Fallah MH, Lowenski S, Sedighi-Moghaddam R, Zavareh A, et al. Spread of West Nile virus in Iran: a cross-sectional serosurvey in equines, 2008-2009. Epidemiol Infect 2011; 139: 1587-1593.

Pourmahdi M, Ghadrdan Mashadi A, Seifi Abad Shapouri M, Zeinvand M. Aserological survey on antibodies against West Nile virus in horses of Khuzestan province. Iran J Vet Med 2013; 7: 185-191.

Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al. Dengue: a continuing global threat. Nat Rev Microbiol 2010; 8: 7-16.

Wilder-Smith A, Renhorn KE, Tissera H, Abu Bakar S, Alphey L, Kittayapong P, et al. DengueTools: innovative tools and strategies for the surveillance and control of dengue. Glob Health Action 2012; 5.

Chinikar S GS, Moradi M, Goya Mm, Shirzadi Mr, Zeinali M, Meshkat M, Bouloy M. Geographical distribution and surveillance of crimean-congo hemorrhagic fever in Iran. Vector Borne Zoonotic Dis 2010; 10: 705-708.

Chinikar S, Ghiasi SM, Shah-Hosseini N, Mostafavi E, Moradi M, Khakifirouz S, et al. Preliminary study of dengue virus infection in Iran. Travel Med Infect Dis 2013; 11: 166-169.

Aghaie A, Aaskov J, Chinikar S, Niedrig M, Banazadeh S, Mohammadpour HK. Frequency of dengue virus infection in blood donors in Sistan and Baluchestan province in Iran. Transfus Apher Sci 2014; 50: 59-62.

Cheraghali AM, Eshghi P, Abolghasemi H. Social consequences of infected haemophilia cases in the Islamic Republic of Iran. East Mediterr Health J 2011; 17: 552-556.

Haghdoost AA , Mostafavi E, Mirzazadeh A, Navadeh S, Feizzadeh A, Fahimfar N, et al. Modelling of HIV/AIDS in Iran up to 2014. J. AIDS HIV Res 2011; 3: 231-239.

Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. Int J Infect Dis 2010; 14: e28-33.

Haghdoost AA, Mirzazadeh A, Shokoohi M, Sedaghat A, Gouya MM. HIV trend among Iranian prisoners in 1990s and 2000s; analysis of aggregated data from HIV sentinel sero-surveys. Harm Reduct J 2013; 10: 32.

Mirzazadeh A, Nedjat S, Navadeh S, Haghdoost A, Mansournia MA, Mcfarland W, et al. HIV and related risk behaviors among female sex workers in Iran: bias-adjusted estimates from the 2010 National Bio-Behavoral Survey. AIDS Behav 2014; 18: 19-24.

Amiri FB, Gouya MM, Saifi M, Rohani M, Tabarsi P, Sedaghat A, et al. Vulnerability of homeless people in Tehran, Iran, to HIV, tuberculosis and viral hepatitis. PLoS One 2014; 9: e98742.

Zadeh AO, Seyedalinaghi S, Hassanzad FF, Hajizadeh M, Mohamadi S, Emamzadeh-Fard S, et al. Prevalence of HIV infection and the correlates among homeless in Tehran, Iran. Asian Pac J Trop Biomed 2014; 4: 65-68.

Ramezani A, Amirmoezi R, Volk JE, Aghakhani A, Zarinfar N, Mcfarland W, et al. HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran. AIDS Care 2014; 26: 1122-1126.

Moradi AR, Emdadi A, Soori B, Mostafavi E. Prevalence of Human Immunodeficiency Virus Infection among Injection Drug Users Released from Jail. Addict Health 2012; 4: 151.

Khajehkazemi R, Osooli M, Sajadi L, Karamouzian M, Sedaghat A, Fahimfar N, et al. HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey. Sex Transm Infect 2013:sextrans-2013-051204.

Nasirian M, Doroudi F, Gooya MM, Sedaghat A, Haghdoost AA. Modeling of human immunodeficiency virus modes of transmission in Iran. J Res Health Sci 2012; 12: 81-87.

Eshrati B, Asl RT, Dell CA, Afshar P, Millson PM, Kamali M, et al. Preventing HIV transmission among Iranian prisoners: initial support for providing education on the benefits of harm reduction practices. Harm Reduct J 2008; 5: 21.

Sarrami-Forooshani R, Das SR, Sabahi F, Adeli A, Esmaeili R, Wahren B, et al. Molecular analysis and phylogenetic characterization of HIV in Iran. J Med Virol 2006; 78: 853-863.

Naderi HR, Tagliamonte M, Tornesello ML, Ciccozzi M, Rezza G, Farid R, et al. Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran. Infect Agent Cancer 2006; 1: 4.

Kanda K, Jayasinghe A, Silva KT, Priyadarshani NG, Delpitiya NY, Obayashi Y, et al. Religious leaders as potential advocates for HIV/AIDS prevention among the general population in Sri Lanka. Glob Public Health 2013; 8: 159-173.

Rhodes T. Risk theory in epidemic times: sex, drugs and the social organisation of ‘risk behaviour’. Sociol Health Illn 1997; 19: 208-227.

Khajehkazemi R, Haghdoost AA, Navadeh S, Setayesh H, Sajadi L, Osooli M, Mostafavi E. Risk and vulnerability of key populations to HIV infection in Iran; knowledge, attitude and practices of female sex-workers, prison inmates and people who inject drugs. Sex Health 2014;11(6):568-574.

Munir S, Saleem S, Idrees M, Tariq A, Butt S, Rauff B, et al. Hepatitis C Treatment: current and future perspectives. Virol J 2010; 7:1-6.

Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45: 529-538.

Rezvan. H, Ahmadi. J, Farhadi. M, S. T. A preliminary study on the prevalence of anti-HCV amongst healthy blood donors in Iran. Vox Sang 1994:100.

Anwar MI, Rahman M, Hassan MU, Iqbal M. Prevalence of active hepatitis C virus infections among general public of Lahore, Pakistan. Virol J 2013; 10: 351.

Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011; 17: 107-115.

Afzal MS, Ahmed T, Zaidi NUSS. Comparison of HCV Prevalence in Pakistan and Iran; An Insight into Future. Hepat Mon 2014; 14: e11466.

Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol 2002; 17: 1092-1097.

Kafi-Abad SA, Rezvan H, Abolghasemi H, Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 2009; 49: 2214-2220.

Khodabandehloo M, Roshani D, Sayehmiri K. Prevalence and trend of hepatitis C virus infection among blood donors in Iran: A systematic review and meta-analysis. J Res Med Sci 2013; 18: 674-682.

Shakeri MT, Nomani H, Ghayour Mobarhan M, Sima HR, Gerayli S, Shahbazi S, et al. The prevalence of hepatitis C virus in mashhad, iran: a population-based study. Hepat Mon 2013; 13: e7723.

Alavian SM, Einollahi B, Hajarizadeh B, Bakhtiari S, Nafar M, Ahrabi S. Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients. Nephrology 2003; 8: 256-260.

Shamshirsaz AA, Kamgar M, Bekheirnia MR, Ayazi F, Hashemi SR, Bouzari N, et al. The role of hemodialysis machines dedication in reducing Hepatitis C transmission in the dialysis setting in Iran: a multicenter prospective interventional study. BMC Nephrol 2004; 5: 13.

Tamaddoni A, Mohammadzadeh I, Ziaei O. Seroprevalence of HCV antibody among patients with beta-thalassemia major in Amirkola Thalassemia Center, Iran. Iran J Allergy Asthma Immunol 2007; 6: 41.

Javadzadeh Shahshahani H, Vaziri M, Mansouri F. Seven Years Trends in Prevalence of Transfusion-Transmissible Viral Infections in Yazd blood Transfusion Organization. Iran J Ped Hematol Oncol 2013; 3: 119-124.

Hajarizadeh B, Alavian S, Mirmomen S. Hepatitis B and C among thalassemiac patients in Iran: A multicenter study. Am J Infect Control 2005; 33: e94.

Sharifi-Mood B, Eshghi P, Sanei-Moghaddam E, Hashemi M. Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran. Saudi Med J 2007; 28: 1516-1519.

Mousavian S, Mansouri F, Saraei A, Sadeghei A, Merat S. Seroprevalence of hepatitis C in hemophilia patients refering to Iran Hemophilia Society Center in Tehran. Govaresh 2011; 16: 169-174.

Karimi M, Ghavanini AA. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus antibodies among multitransfused thalassaemic children in Shiraz, Iran. J Paediatr Child Health 2001; 37: 564-566.

Alavian SM. Control of Hepatitis C in Iran: Vision and Missions. Hepat Mon 2007; 7: 57-58.

Joukar F, Besharati S, Mirpour H, Mansour-Ghanaei F. Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran: HCV and HBV seroprevalence in hemodialysis patients. Hepat Mon 2011; 11: 178-181.

Kalantari H, Ebadi S, Yaran M, Maracy MR, Shahshahan Z. Prevalence and risk factors of hepatitis B and C viruses among hemodialysis patients in Isfahan, Iran. Adv Biomed Res 2014; 3: 73.

Somi MH, Etemadi J, Ghojazadeh M, Farhang S, Faramarzi M, Foroutan S, et al. Risk Factors of HCV Seroconversion in Hemodialysis Patients in Tabriz, Iran. Hepat Mon 2014; 14: e17417.

Alavian SM, Kabir A, Ahmadi AB, Lankarani KB, Shahbabaie MA, Ahmadzad-Asl M. Hepatitis C infection in hemodialysis patients in Iran: a systematic review. Hemodial Int 2010; 14: 253-262.

Shahmoradi S, Yahyapour Y, Mahmoodi M, Alavian SM, Fazeli Z, Jazayeri SM. High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG. J Hepatol 2012; 57: 515-521.

Habibollahi P, Safari S, Daryani NE, Alavian SM. Occult hepatitis B infection and its possible impact on chronic hepatitis C virus infection. Saudi J Gastroenterol 2009; 15: 220-224.

Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis 2002; 2: 479-486.

Honarkar Z, Alavian SM, Samiee S, Saeedfar K, Zali MR. Occult hepatitis B among chronic liver disease patients. Saudi Med J 2005; 26: 601-606.

Ramezani A, Banifazl M, Eslamifar A, Aghakhani A. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. J Infect Dev Ctries 2010; 4: 658-661.

Azadmanesh K, Mohraz M, Aghakhani A, Edalat R, Jam S, Eslamifar A, et al. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody. Intervirology 2008; 51: 270-274.

Aghakhani A, Banifazl M, Kalantar E, Eslamifar A, Ahmadi F, Razeghi E, et al. Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study. Ther Apher Dial 2010; 14: 349-353.

Jafarzadeh A, Arababadi MK, Pourazar MMA. Occult hepatitis B virus infection among blood donors with antibodies to hepatitis B core antigen. Acta Medica Iranica 2008; 46: 27-32.

Behzad-Behbahani A, Mafi-Nejad A, Tabei S, Lankarani K, Rashidi M, Rasouli M, et al. Indication of anti-HBc antibody screening and HBV-DNA detection in diagnosing latent hepatitis B virus infection. Iran J Med Sci 2015; 30: 28-33.

Pourazar A, Salehi M, Jafarzadeh A, Arababadi MK, Oreizi F, Shariatinezhad K. Detection of HBV DNA in HBsAg negative normal blood donors. IJI 2005; 2: 172-176.

Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407-410.

Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. PNAS 1981; 78: 6476-6480.

Gessain A, Cassar O. HTLV-1 world distribution and estimation of the number of asymptomatic infected carriers. Retrovirology 2014; 11: 14-14.

Popovic M, Sarin PS, Robert-Gurroff M, Kalyanaraman VS, Mann D, Minowada J, et al. Isolation and transmission of human retrovirus (human t-cell leukemia virus). Science 1983; 219: 856-859.

Farid R, Poryamoth N, Godarzi A, Rafatpanah H, Amin H, Gessain A. Afamilial seroepidemiological survey of HTLV-1 in Mashhad, Northeastern Iran suggested an important mother to childtransmision. J AIDS Hum Retrovirol 1995; 10: 209-212.

Achiron A, Pinhas-Hamiel O, Doll L, Djaldetti R, Chen A, Ziv I, et al. Spastic paraparesis associated with human T-lymphotropic virus type I: a clinical, serological, and genomic study in Iranian-born Mashhadi Jews. Ann Neurol 1993; 34: 670-675.

Meytes D, Elgat M, Schochat B, Sidi Y, Shaklai M, Kilim Y, et al. Serological and molecular survey for HTLV-I infection in a high-risk Middle Eastern group. The Lancet 1990; 336: 1533-1535.

Sidi Y, Meytes D, Shohat B, Fenig E, Weisbort Y, Lee H, et al. Adult T-cell lymphoma in Israeli patients of Iranian origin. Cancer 1990; 65: 590-593.

Farid R, Shirdel A, Tabei S. Clinical manifestation of adult T cell lymphoma/leukemia associated with HTLV-I in north-eastern Iran. Iranian J Med Sci 1992; 17: 105-108.

Gabarre J, Gessain A, Raphael M, Merle-Beral H, Dubourg O, Fourcade C, et al. Adult T-cell leukemia/lymphoma revealed by a surgically cured cardiac valve lymphomatous involvement in an Iranian woman: clinical, immunopathological and viromolecular studies. Leukemia 1993; 7: 1904-1909.

Farid R, Etemadi M, Baradaran H, Nikbin B. Seroepidemiology and virology of HTLV-1 in the city of Mashhad, northeastern Iran. Serodiag Immun Inf D 1993; 5: 251-252.

Rezvan H, Ahmadi J, Farhadi M. A cluster of HTLV-1 infection in northeastern of Iran. Transfusion Today 1996; 7: 8-9.

Safai B, Huang J-L, Boeri E, Farid R, Raafat J, Schutzer P, et al. Prevalence of HTLV type I infection in Iran: a serological and genetic study. ‎AIDS Res Hum Retr 1996; 12: 1185-1190.

Abbaszadegan MR, Gholamin M, Tabatabaee A, Farid R, Houshmand M, Abbaszadegan M. Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran. J Clin Microbiol 2003; 41: 2593-2595.

Tarhini M, Kchour G, Zanjani DS, Rafatpanah H, Otrock ZK, Bazarbachi A, et al. Declining tendency of human T-cell leukaemia virus type I carrier rates among blood donors in Mashhad, Iran. Pathology 2009; 41: 498-499.

Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, et al. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol 2011; 52: 172-176.

Azarpazhooh MR, Hasanpour K, Ghanbari M, Rezaee SA, Mashkani B, Hedayati-Moghaddam MR, et al. Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis. AIDS Res Hum Retroviruses 2012; 28: 1095-1101.

Hedayati-Moghaddam MR, Fathimoghadam F, Eftekharzadeh Mashhadi I, Soghandi L, Bidkhori HR. Epidemiology of HTLV-1 in Neyshabour, Northeast of Iran. Iran Red Crescent Med J 2011; 13: 424-427.

Karimi A, Nafici M, Imani R. Comparison of human T-cell leukemia virus type-1 (HTLV-1) seroprevalence in high risk patients (thalassemia and hemodialysis) and healthy individuals from Charmahal-Bakhtiari province, Iran. Kuwait Med J 2007; 39: 259.

Khameneh ZR, Baradaran M, Sepehrvand N. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia. Saudi J Kidney Dis Transpl 2008; 19: 838-841.

Abedian F, Yavarian M, Shakibzadeh A, Khalvati B, Asadi A. A pilot Seroepidemiologic study of HTLV in thalassemia, hemophilia, and hemodialysed patients in Hormozgan. HMJ 2009; 13: 75-80.

Kendall EA, Gonzalez E, Espinoza I, Tipismana M, Verdonck K, Clark D, et al. Early neurologic abnormalities associated with human T-cell lymphotropic virus type 1 infection in a cohort of Peruvian children. J Pediatr 2009; 155: 700-706.

Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005; 24: 6058-6068.

Vrielink H, Reesink HW. HTLV-I/II prevalence in different geographic locations. Transfus Med Rev 2004; 18: 46-57.

Trifonov V, Khiabanian H, Rabadan R. Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus. N Engl J Med 2009; 361: 115-119.

Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360: 2605-2615.

Gooya MM, Soroush M, Mokhtari-Azad T, Haghdoost AA, Hemati P, Moghadami M, et al. Influenza A (H1N1) pandemic in Iran: report of first confirmed cases from June to November 2009. Arch Iran Med 2010; 13: 91-98.

Dashti-Khavidaki S, Khalili H, Gholamalipour F, Soudbakhsh A, Talasaz AH, Hajabdolbaghi M, et al. Approach to Pandemic 2009 influenza: first report from a main referral hospital for Pandemic H1N1 influenza care in Iran. J Infect Dev Ctries 2010; 4: 629-635.

Afrasiabian S, Mohsenpour B, Bagheri KH, Barari M, Ghaderi E, Hashemi R, et al. Epidemiological survey on pandemic influenza A (H1N1) virus infection in Kurdistan province, Islamic Republic of Iran, 2009. East Mediterr Health J 2014; 20: 169-174.

Ziyaeyan M, Alborzi A, Jamalidoust M, Moeini M, Pouladfar GR, Pourabbas B, et al. Pandemic 2009 influenza A (H1N1) infection among 2009 Hajj Pilgrims from Southern Iran: a real-time RT-PCR-based study. Influenza Other Respir Viruses 2012; 6: 80-84.

Haghdoost AA, Gooya MM, Baneshi MR. Modelling of H1N1 flu in Iran. Arch Iran Med 2009; 12: 533-541.

Assiri A, Mcgeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 2013; 369: 407-416.

Cunha CB, Opal SM. Middle East respiratory syndrome (MERS): a new zoonotic viral pneumonia. Virulence 2014; 5: 650-654.

Ithete NL, Stoffberg S, Corman VM, Cottontail VM, Richards LR, Schoeman MC, et al. Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis 2013; 19: 1697-1699.

Mailles A, Blanckaert K, Chaud P, Van Der Werf S, Lina B, Caro V, et al. First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro Surveill 2013; 18: pii: 20502.

Haagmans BL, Al Dhahiry SH, Reusken CB, Raj VS, Galiano M, Myers R, et al. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis 2014; 14: 140-145.

Yavarian J, Rezaei F, Shadab A, Soroush M, Gooya MM, Azad TM. Cluster of Middle East respiratory syndrome coronavirus infections in Iran, 2014. Emerg Infect Dis 2015; 21: 362-364.

Tabatabaei S, Zahraei M, Ahmadnia H, Ghotbi M, Rahimi F. Principles of disease prevention and surveillance. Tehran: roohe ghalam. 2007.

Guery B, Poissy J, El Mansouf L, Séjourné C, Ettahar N, Lemaire X, et al. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. The Lancet 2013; 381: 2265-2272.

Oie. Available at: Accessed December 8, 2014. 2014.

Weigler BJ. Zoonotic hantaviruses; new concerns for the United States. J Am Vet Med Assoc 1995; 206: 979-986.

Hu XQ, Li SG, Liu H, Wang J, Hua RM. Diversity and distribution of host animal species of hantavirus and risk to human health in Jiuhua mountain area, China. Biomed Environ Sci 2014; 27: 849-857.

Oncul O, Atalay Y, Onem Y, Turhan V, Acar A, Uyar Y, et al. Hantavirus infection in Istanbul, Turkey. Emerg Infect Dis 2011; 17: 303-304.

Gozalan A, Kalaycioglu H, Uyar Y, Sevindi DF, Turkyilmaz B, Çakir V, et al. Human puumala and dobrava hantavirus infections in the Black Sea region of Turkey: a cross-sectional study. Vector Borne Zoonotic Dis 2013; 13: 111-118.

Chinikar S, Javadi AA, Hajiannia A, Ataei B, Jalali T, Khakifirouz S, et al. First Evidence of Hantavirus in Central Iran as an Emerging Viral Disease. Advances in Infectious Diseases 2014; 4: 173.

Arricau-Bouvery N, Rodolakis A. Is Q fever an emerging or re-emerging zoonosis? Vet Res 2005; 36: 327-349.

Kaplan MM, Bertagna P. The geographical distribution of Q fever. Bull World Health Organ 1955; 13: 829-860.

Caughey J, Harootunian S. Q fever in Iran. The Lancet 1976; 308: 638.

Esmaeili S, Pourhossein B, Gouya MM, Amiri FB, Mostafavi E. Seroepidemiological survey of Q fever and brucellosis in Kurdistan Province, western Iran. Vector Borne Zoonotic Dis 2014; 14: 41-45.

Khalili M, Mosavi M, Diali HG, Mirza HN. Serologic survey for Coxiella burnetii phase II antibodies among slaughterhouse workers in Kerman, southeast of Iran. Asian Pac J Trop Biomed 2014; 4: 209-212.

Mostafavi E, Rastad H, Khalili M. Q Fever: An emerging public health concern in Iran. Asian J. Epidemiol 2012; 5: 66.

Khalili M, Sakhaee E. An update on a serologic survey of Q Fever in domestic animals in Iran. Am J Trop Med Hyg 2009; 80: 1031-1032.

Sakhaee E, Khalili M. The first serologic study of Q fever in sheep in Iran. Trop Anim Health Prod 2010; 42: 1561-1564.

Asadi J, Kafi M, Khalili M. Seroprevalence of Q fever in sheep and goat flocks with a history of abortion in Iran between 2011 and 2012. Vet Ital 2013; 49: 163-168.

Rahimi E, Doosti A, Ameri M, Kabiri E, Sharifian B. Detection of Coxiella burnetii by nested PCR in bulk milk samples from dairy bovine, ovine, and caprine herds in Iran. Zoonoses Public Health 2010; 57:38-41.

Ghalyanchi Langeroudi A, Babkhani N, Zolfaghari MR, Majidzadeh Arbadili K, Morovvati A, Soleimani M. Detection of Coxeilla brunetii in bulk tank milk samples from dairy bovine farms using nested-PCR in Qom, Iran, 2011. Iran J Arthropod Borne Dis 2013; 7: 207-211.

Khalili M, Sakhaee E, Aflatoonian MR, Shahabi-Nejad N. Herd-prevalence of Coxiella burnetii (Q fever) antibodies in dairy cattle farms based on bulk tank milk analysis. Asian Pac J Trop Med 2011; 4: 58-60.

Fard SRN, Khalili M. PCR-Detection of Coxiella burnetii in Ticks Collected from Sheep and Goats in Southeast Iran. Iran J Arthropod Borne Dis 2011; 5: 1-6.

Bos KI, Schuenemann VJ, Golding GB, Burbano HA, Waglechner N, Coombes BK, et al. A draft genome of Yersinia pestis from victims of the Black Death. Nature 2011; 478: 506-510.

Nekouie H, Razavi MR, Seyedipoor G. Investigation of Yersinia pestis in Xenopsylla astia. Southeast Asian J Trop Med Public Health 2003; 34: 158-161.

Leslie T, Whitehouse CA, Yingst S, Baldwin C, Kakar F, Mofleh J, et al. Outbreak of gastroenteritis caused by Yersinia pestis in Afghanistan. Epidemiol Infect 2011; 139: 728-735.

Dols MW. Plague in early Islamic history. J Am Orient Soc 1974:371-383.

Heggs TB. Pneumonic plague in Iraq. Trans R Soc Trop Med Hyg 1924; 18: 45-49.

Drancourt M, Raoult D. Molecular insights into the history of plague. Microbes Infect 2002; 4: 105-109.

Gurbanov S, Akhmedova S. Especially dangerous infections in Azerbaijan. Emerging and Endemic Pathogens: Springer; 2010 39-43.

Aikimbajev A, Meka-Mechenko T, Temiralieva G, Bekenov J, Sagiyev Z, Kaljan K, et al. Plague in Kazakhstan at the present time. Przegl Epidemiol 2003; 57: 593-598.

Todd. E, R S. Plague In Egypt. Br Med J 1952; 1: 582-584.

Perry RD, Fetherston JD. Yersinia pestis--etiologic agent of plague. Clin Microbiol Rev 1997; 10: 35-66.

Théodoridès J. Un grand épidémiologiste franco-mauricien: Joseph Désiré Tholozan (1820-1897). Bull Soc Pathol Exot 1998; 91: 104-108.

Azizi MH, Azizi F. A history of the human plague in Iran. Arch Iran Med 2010; 13: 563-569.

Kohn GC. Encyclopedia of plague and pestilence: from ancient times to the present: Infobase Publishing; 2007.

Yousefi Behzadi M, Mostafavi E. A Historical Report of Plague Outbreak in Northern Kermanshah Province, Western Iran, in 1952.‎ J Hist Med Allied Sci 2014;3.

Drancourt M, Raoult D. Molecular insights into the history of plague. Microbes and infection 2002; 4: 105-109.

Y K. Plague and its Epidemiology. 1 th ed. Tehran: Pasteur Institute of Iran. 1976.

Esamaeili S, Azadmanesh K, Naddaf SR, Rajerison M, Carniel E, Mostafavi E. Serologic Survey of Plague in Animals, Western Iran. Emerg Infect Dis 2013; 19: 1549-1551.

Sjostedt A. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci 2007; 1105: 1-29.

Sandstrom G, Sjostedt A, Forsman M, Pavlovich NV, Mishankin BN. Characterization and classification of strains of Francisella tularensis isolated in the central Asian focus of the Soviet Union and in Japan. J Clin Microbiol 1992; 30: 172-175.

Katherine AF, Donna S-E, Kathleen J, Bela TM, Sam RT, May CC, et al. Tularemia on Martha’s Vineyard: Seroprevalence and Occupational Risk. Emerg Infect Dis 2003; 9: 350.

Ohara Y, Sato T, Homma M. Epidemiological analysis of tularemia in Japan (yato-byo). FEMS Immunol Med Microbiol 1996; 13: 185-189.

Esmaeili S, Esfandiari B, Maurin M, Gouya MM, Shirzadi MR, Amiri FB, et al. Serological survey of tularemia among butchers and slaughterhouse workers in Iran. Trans R Soc Trop Med Hyg 2014; 108: 516-518.

Helvacı S, Gedikoğlu S, Akalın H, Oral H. Tularemia in Bursa, Turkey: 205 cases in ten years. Eur J Epidemiol 2000; 16: 271-276.

Clark DV, Ismailov A, Seyidova E, Hajiyeva A, Bakhishova S, Hajiyev H, et al. Seroprevalence of tularemia in rural Azerbaijan. Vector Borne Zoonotic Dis 2012; 12: 558-563.

Farhang-Azad A, Mescerjakova I, Neronov V. Afghan hedgehog, a new reservoir of tularemia. Bull Soc Pathol Exot Filiales 1973; 66: 266-269.

Arata A, Chamsa H, Farhang-Azad A, Mescerjakova O, Neronov V, Saidi S. First detection of tularaemia in domestic and wild mammals in Iran. Bull World Health Organ 1973; 49: 597-603.

Khoshdel A, Saedi Dezaki E, Ganji F, Habibian R, Imani R, Taheri E, et al. First Seroprevalence Survey of Children with Tularemia Infection in Chaharmahal va Bakhtiari Province, Iran. Iran J Pathol 2014; 9: 23-27.

Esmaeili S, Gooya MM, Shirzadi MR, Esfandiari B, Amiri FB, Behzadi MY, et al. Seroepidemiological survey of tularemia among different groups in western Iran. Int J Infect Dis 2014; 18: 27-31.

Khosravi M, Bastani B. Acute renal failure due to leptospirosis in a renal transplant recipient: a brief review of the literature. Transplant Proc 2007; 39: 1263-1266.

Adler B, De La Pena Moctezuma A. Leptospira and leptospirosis. Vet Microbiol 2010; 140: 287-296.

Rafyi A, Maghami G. On the frequency of leptospirosis in Iran. Isolation of Leptospira grippo-typhosa in men and in cattle. (Second note). Bull Soc Pathol Exot Filiales 1958; 52: 592-596.

Rafyi A, Maghami G. On the incidence of leptospirosis in Iran. III. Isolation of Leptospira grippo-typhosa (L. bovis) in sheep. Bull Soc Pathol Exot Filiales 1960; 54: 179-181.

Maghami GH, Hooshmand-Rad P, Farhang-Azad A. Leptospirosis in small mammals of Iran: II: isolation of Leptospira grippotyphosa from Mus msuculus. J Wildl Dis 1977; 13: 286-289.

Hooshmand-Rad P, Maghami G. Leptospirosis in small mammals of Iran: I. Serologic tests and isolation of Leptospira hebdomadis from Apodemus sylvaticus. J Wildl Dis 1976; 12: 34-38.

Sebek Z, Bashiribod H, Chaffari M, Sepasi F, Sixl W. The occurrence of leptospirosis in Iran. J Hyg Epidemiol Microbiol Immunol 1987; 31: 498-503.

Mansour-Ghanaei F, Sarshad A, Fallah MS, Pourhabibi A, Pourhabibi K, Yousefi-Mashhoor M. Leptospirosis in Guilan, a northern province of Iran: assessment of the clinical presentation of 74 cases. Med Sci Monit 2005; 11: 219-223.

Honarmand H, Mansour GF, Heydarzadeh A, Asmar M. Isolation and Serotyping of endemic leptospires of eastern part of flat area of Guilan province, Iran. J Gorgan Univ Med Sci 2009; 11: 53-59.

Aghaiypour K, Safavieh S. Molecular detection of pathogenic Leptospira in Iran. Arch Razi Inst 2016; 62: 191-197.

Zakeri S, Sepahian N, Afsharpad M, Esfandiari B, Ziapour P, Djadid ND. Molecular epidemiology of leptospirosis in northern Iran by nested polymerase chain reaction/restriction fragment length polymorphism and sequencing methods. Am J Trop Med Hyg 2010; 82: 899-903.

Esfandiari B, Ziapour S, Assmar M, Youssefi M, Amirbozorgi G, Navaie BA, et al. Leptospirosis in Mazandaran province, northern Iran, 2008-2009. J Infect Dis Med 2010; 14: 211-212.

Alavi SM, Khoshkho MM. Seroprevalence Study of Leptospirosis Among Rice Farmers in Khuzestan Province, South West Iran, 2012. Jundishapur J Microbiol 2014; 7: e11536.

Garoussi MT, Vand-E-Useefee J, Mehrzad J. Seroprevalence of Leptospiral Infection in Rodents of Dairy Cattle Herds Complexes in Suburb of Mashhad-Iran. J Appl Anim Res 2006; 30: 109-111.

Ziapour S, Esfandiari B, Abdollahpour G, Assmar M, Youssefi M, Amirbozorgi G, et al. The Survey of leptospirosis in Mazandaran province, north of Iran by Microscopic agglutination test, 2006-2007. J Infect Dis Med 2010; 14: e206.

Khousheh Y, Hassanpour A, Abdollahpour G, Mogaddam S. Seroprevalence of Leptospira Infection in Horses in Ardabil-Iran. Glob Vet 2012; 9: 586-589.

Hajikolaei MRH, Haidari M, Abdollapour G. Comparison of leptospiral infection in the horse and donkey. Bull Vet Inst Pulawy 2005; 49: 175-178.

Shafighi T, Abdollahpour G, Salehi TZ, Tadjbakhsh H. Serological and bacteriological study of leptospirosis in slaughtered cattle in north of Iran (Rasht). Afr J Microbiol Res 2010; 4: 2118-2121.

Ebrahimi A, Nasr Z, Kojouri GA. Seroinvestigation of bovine leptospirosis in Shahrekord district, central Iran. Iran J Vet Res 2004; 4: 370-371.

Abdollahpour G, Shafighi ST, Sattari Tabrizi S. Serodiagnosis of leptospirosis in cattle in north of Iran, Gilan. Iran J Vet Med 2009;3: 7-10.

Khalili M, Sakhaee E, Aflatoonian MR, Abdollahpour G, Tabrizi SS, Damaneh EM, et al. Seroprevalence of bovine leptospiral antibodies by microscopic agglutination test in Southeast of Iran. Asian Pac J Trop Biomed 2014; 4: 354-357.

Hamali H, Jafari Joozani R, Abdollahpour G. Serodiagnosis and molecular survey on leptospiral abortions in the dairy cattle of Tabriz. Iranian J Vet Res 2012; 13: 120-125.

Rad M, Zeinali A, Vand Y, Tabatabayi A, Bokaie S. Seroprevalence and bacteriological study of canine leptospirosis in Tehran and its suburban areas. Iranian J Vet Res 2004; 5: 1383-1389.

Alavi SM, Khoshkho MM. Seroprevalence Study of Leptospirosis Among Rice Farmers in Khuzestan Province, South West Iran, 2012. Jundishapur J Microbiol 2014; 7: e11536.

Tooloei M, Abdollapour G, Karimi H, Hasanpor A. Prevalence of serum antibodies against six Leptospira serovars in sheep in Tabriz, Northwestern Iran. Adv Anim Vet Sci 2008; 8: 333-336.

Jamshidi S, Akhavizadegan M, Maazi N, Ali AG, Bokaie S. Serologic study of feline leptospirosis in Tehran, Iran. Iran J Microbiol 2009;1: 32-36.

Mosallanejad B, Avizeh R, Abdollahpoor G, Abadi K. A serological survey of Leptospiral infection of cats in Ahvaz, south-western of Iran. Iran J Vet Med 2011; 5: 49-52.

Alavi L, Alavi SM, Khoshkho MM. Risk Factors of Leptospirosis in Khuzestan, South West of Iran, 2012. Int J Enteric Pathog 2013; 1: 68-71.

Nasiri MJ, Dabiri H, Darban-Sarokhalil D, Rezadehbashi M, Zamani S. Prevalence of drug-resistant tuberculosis in Iran: Systematic review and meta-analysis. Am J Infect Control 2014; 42: 1212-1218.

Bahrmand AR, Velayati AA, Bakayev VV. Treatment monitoring and prevalence of drug resistance in tuberculosis patients in Tehran. Int J Tuberc Lung Dis 2000; 4: 544-549.

Heidarnejad H, Nagili B. Primary Resistance of Mycobacterium tuberculosis to isoniazid, streptomycin, rifampin, and ethambutol in pulmonary tuberculosis. Arch of Iranian Med 2001 4: 1-4.

Haeili M, Darban-Sarokhalil D, Fooladi AA, Javadpour S, Hashemi A, Siavoshi F, et al. Spoligotyping and drug resistance patterns of Mycobacterium tuberculosis isolates from five provinces of Iran. Microbiologyopen 2013; 2: 988-996.

Namaei MH, Sadeghian A, Naderinasab M, Ziaee M. Prevalence of primary drug resistant Mycobacterium tuberculosis in Mashhad, Iran. Indian J Med Res 2006; 124: 77-80.

Farivar TN, Naderi M, Fard AM, Oweist H, Moud BS. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in South Eastern of Iran. Am J Med Sci 2006; 6: 275-278.

Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, et al. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran-eight years of surveillance. Int J Infect Dis 2009; 13: 236-240.

Metanat M, Sharifi-Mood B, Shahreki S, Dawoudi SH. Prevalence of multidrug-resistant and extensively drug-resistant tuberculosis in patients with pulmonary tuberculosis in zahedan, southeastern iran. Iran Red Crescent Med J 2012; 14: 53-55.

Sharifi Yazdi MK. Primary drug resistance patterns in newly diagnosed tuberculosis patients in Yazd, southern province of Iran. Afr J Biotechnol 2012; 11: 702-706.

Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, Van Soolingen D, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. The Lancet 2010; 375: 1830-1843.

Masjedi MR, Farnia P, Sorooch S, Pooramiri MV, Mansoori SD, Zarifi AZ, et al. Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran. Clin Infect Dis 2006; 43: 841-847.

Velayati AA, Farnia P, Masjedi MR, Ibrahim TA, Tabarsi P, Haroun RZ, et al. Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level. Eur Respir J 2009; 34: 1202-1203.

Bostanabad SZ, Shekarabei M, Nojoumi SA, Jabbarzadeh E, Ghalami M, Kazemi VM, et al. Study of genetic evolution in Mycobacterium tuberculosis isolates from patients with active pulmonary tuberculosis in the Iran and Belarus. Open Microbiol J 2011; 5: 32-42.

Shojaei H, Heidarieh P, Hashemi A, Feizabadi MM, Daei Naser A. Species identification of neglected nontuberculous mycobacteria in a developing country. Jpn J Infect Dis 2011; 64: 265-271.

Samra Z, Kaufman L, Pitlik S, Shalit I, Bishara J. Emergence of Mycobacterium simiae in respiratory specimens. Scand J Infect Dis 2005; 37: 838-841.

Piersimoni C, Scarparo C. Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patients. Lancet Infect Dis 2008; 8: 323-334.

Tabarsi P, Baghaei P, Farnia P, Mansouri N, Chitsaz E, Sheikholeslam F, et al. Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis-need for earlier identification of nontuberculosis mycobacteria. Am J Med Sci 2009; 337: 182-184.

Hashemi-Shahraki A, Bostanabad SZ, Heidarieh P, Titov LP, Khosravi AD, Sheikhi N, et al. Species spectrum of nontuberculous mycobacteria isolated from suspected tuberculosis patients, identification by multi locus sequence analysis. Infect Genet Evol 2013; 20: 312-324.

Shojaei H, Hashemi A, Heidarieh P, Daei-Naser A. Chronic pelvic pain due to Mycobacterium parascrofulaceum in an Iranian patient: first report of isolation and molecular characterization from Asia. Braz J Infect Dis 2011; 15: 186-187.

Shamaei M, Marjani M, Farnia P, Tabarsi P, Mansouri D. Human infections due to Mycobacterium lentiflavum: first report in Iran. Iran J Microbiol 2010; 2: 27-29.

Shojaei H, Hashemi A, Heidarieh P, Ataei B, Naser AD. Pulmonary and extrapulmonary infection caused by Mycobacterium conceptionense: the first report from Iran. JRSM short reports 2011; 2: 31.

Shojaei H, Hashemi A, Heidarieh P, Naser AD. Mycobacterium novocastrense-associated pulmonary and wound infections. Emerg Infect Dis 2011; 17: 550-551.

Shojaei H, Hashemi A, Heidarieh P, Hosseini N, Daei Naser A. Chronic pulmonary disease due to Mycobacterium monacense infection: the first case from Iran. Ann Lab Med 2012; 32: 87-90.

Shojaei H, Hashemi A, Heidarieh P, Feizabadi MM, Ataei B, Naser AD. First report on isolation and molecular characterization of clinical Mycobacterium setense isolates in Asia. Jpn J Infect Dis 2011; 64: 234-236.

Heidarieh P, Shojaei H, Hashemi A, Feizabadi MM, Daei-Naser A, Ataei B. First report of isolation of Mycobacterium elephantis from bronchial lavage of a patient in Asia. JRSM Short Rep 2011;2: 26.

Pourahmad F, Shojaei H, Heidarieh P, Khosravi A, Hashemi A. Report of two cases of Mycobacterium europaeum from Iran. Jpn J Infect Dis 2012; 65: 539-541.

Saeed Zaker B. Isolation of Mycobacterium Chelonae in the Sputum and Cervical Lymph Nodes of Patient with Metastatic Breast Cancer. Mycobact Diseases 2012; 2: 106.

Shojaei H, Daley C, Gitti Z, Hashemi A, Heidarieh P, Moore ER, et al. Mycobacterium iranicum sp. nov., a rapidly growing scotochromogenic species isolated from clinical specimens on three different continents. Int J Syst Evol Microbiol 2013; 63: 1383-1389.

Shahraki AH, Çavuşoğlu C, Borroni E, Heidarieh P, Koksalan OK, Cabibbe AM, et al. Mycobacterium celeriflavum sp. nov., a rapidly growing scotochromogenic bacterium isolated from clinical specimens. Int J Syst Evol Microbiol 2015; 65: 510-515.

Nierman WC, Deshazer D, Kim HS, Tettelin H, Nelson KE, Feldblyum T, et al. Structural flexibility in the Burkholderia mallei genome. PNAS 2004; 101: 14246-14251.

Srinivasan A, Kraus CN, Deshazer D, Becker PM, Dick JD, Spacek L, et al. Glanders in a military research microbiologist. N Engl J Med 2001; 345: 256-258.

Control CFD, Prevention. Laboratory-acquired human glanders-Maryland, May 2000. MMWR Morb Mortal Wkly Rep 2000; 49: 532.

Kashani-Sabet F. “City of the Dead”: The Frontier Polemics of Quarantines in the Ottoman Empire and Iran. Comparative Studies of South Asia, Africa and the Middle East 1998; 18: 51-58.

Khaki P, Mosavari N, Khajeh NS, Emam M, Ahouran M, Hashemi S, et al. Glanders outbreak at Tehran Zoo, Iran. Iran J Microbiol 2012; 4: 3-7.

Marcilla A, Bargues MD, Mas-Coma S. A PCR-RFLP assay for the distinction between Fasciola hepatica and Fasciola gigantica. Mol Cell Probes 2002; 16: 327-333.

Mas-Coma S. Epidemiology of fascioliasis in human endemic areas. J Helminthol 2005; 79: 207-216.

Rokni MB, Massoud J, O'neill SM, Parkinson M, Dalton JP. Diagnosis of human fasciolosis in the Gilan province of Northern Iran: application of cathepsin L-ELISA. Diagn Microbiol Infect Dis 2002; 44: 175-179.

Massoud J. The importance of helminthic diseases in Iran. Pro-ceedings of the 2nd National Congress of Parasitic Diseases in Iran. Tehran, Iran. pp 74. 1997.

Delkhosh J, Noorsalehi S. Report of human fasciolosis in Gilan Province (1984-1995). 2nd National Congress of Parasitic Diseases, Tehran, Iran. October 17. 1997.

Bahonar A, Poya B. A descriptive epidemiology of patients infected with fasciolosis in Rasht and Bandar Anzali in 1999. 3rd National Congress of Medical Parasitology, 2000, Sari, Iran, April 9-11. 2000.

Ahmadi NA, Meshkehkar M. Prevalence and long term trend of liver fluke infections in sheep, goats and cattle slaughtered in Khuzestan, southwestern Iran. J Paramed Sci 1: 26-31.

Moghaddam AS, Massoud J, Mahmoodi M, Mahvi AH, Periago MV, Artigas P, et al. Human and animal fascioliasis in Mazandaran province, northern Iran. Parasitol Res 2004; 94: 61-69.

Saki J, Khademvatan S, Yousefi E. Molecular identification of animal Fasciola isolates in Southwest of Iran. Aust J Basic Appl Sci 2011; 5: 1878-1883.

Amor N, Halajian A, Farjallah S, Merella P, Said K, Ben Slimane B. Molecular characterization of Fasciola spp. from the endemic area of northern Iran based on nuclear ribosomal DNA sequences. Exp Parasitol 2011; 128: 196-204.

Imani-Baran A, Yakhchali M, Malekzadeh Viayeh R, Paktarmani R. Molecular study for detecting the prevalence of Fasciola gigantica in field-collected snails of Radix gedrosiana (Pulmonata: Lymnaeidae) in northwestern Iran. Vet Parasitol 2012; 189: 374-377.

Sarkari B, Ghobakhloo N, Moshfea A, Eilami O. Seroprevalence of human fasciolosis in a new-emerging focus of fasciolosis in yasuj district, southwest of Iran. Iran J Parasitol 2012; 7: 15-20.

Rahimi P, Ghavami M, Haniloo A, Nourian A, Biglari A. Identification of Fasciola Species by PCR-RFLP Assay. ZUMS Journal 2009; 16: 41-48.

Ashrafi K, Valero M, Forghan-Parast K, Rezaeian M, Shahtaheri S, Hadiani M, et al. Potential transmission of human fascioliasis through traditional local foods, in northern Iran. Iran J Public Health 2006; 35: 49-56.

Ashrafi K, Valero MA, Massoud J, Sobhani A, Solaymani-Mohammadi S, Conde P, et al. Plant-borne human contamination by fascioliasis. Am J Trop Med Hyg 2006; 75: 295-302.

Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005; 434: 214-217.

Vatandoost H, Emami S, Oshaghi M, Abai M, Raeisi A, Piazzak N, et al. Ecology of malaria vector Anopheles culicifacies in a malarious area of Sistan va Baluchestan province, south-east Islamic Republic of Iran/Écologie du vecteur du paludisme Anopheles culicifacies dans une région impaludée de la province du Sistan-Baloutchistan, au sud-est de la République islamique d'Iran. East Mediterr Health J 2011; 17: 439.

Afsharpad M, Zakeri S, Pirahmadi S, Djadid ND. Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran. Acta Trop 2012; 121: 13-18.

Suroso T, Hamidi AN, Manouchehri AV. The activity of chloroquine against Plasmodium falciparum in Bandar Abbas, Southern Iran, 1976. Bull Soc Pathol Exot Filiales 1978; 71: 164-171.

Edrissian G. Malaria in Iran: Past and present situation. Iran J Parasitol 2006; 1: 1-14.

Edrisian GH, Nateghpour M, Afshar A, Seyedzadeh A, Mohseni G, Satvat M, et al. Monitoring the response of Plasmodium falciparum and Plasmodium vivax to antimalarial drugs in the malarious areas in south-east Iran. Arch Iran Med 1999; 2: 61-66.

Edrissian GH, Afshar A, Kanani A, Satvat MT, Mohsseni G, Nasseri-Nejad K, et al. The response of Plasmodium falciparum to chloroquine and mefloquine in Bandar-Abbas and Minab areas, Hormozgan Province, southern Iran. J Trop Med Hyg 1989; 92: 75-79.

Wilson CM, Volkman SK, Thaithong S, Martin RK, Kyle DE, Milhous WK, et al. Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol Biochem Parasitol 1993; 57: 151-160.

Raeisi A, Ringwald P, Safa O, Shahbazi A, Ranjbar M, Keshavarz H, et al. Monitoring of the therapeutic efficacy of chloroquine for the treatment of uncomplicated, Plasmodium falciparum malaria in Iran. Ann Trop Med Parasitol 2006; 100: 11-16.

Tabatabaie F, Abrehdari Tafreshi Z, Shahmohammad N, Pirestani M. Molecular detection of microsporidiosis in various samples of Iranian immunocompromised patients. J Parasit Dis 2015; 39: 634-638.

Jamshidi S, Tabrizi AS, Bahrami M, Momtaz H. Microsporidia in household dogs and cats in Iran; a zoonotic concern. Vet Parasitol 2012; 185: 121-123.

Agholi M, Hatam GR, Motazedian MH. HIV/AIDS-associated opportunistic protozoal diarrhea. AIDS Res Hum Retroviruses 2013; 29: 35-41.

Mirjalali H, Mohebali M, Mirhendi H, Gholami R, Keshavarz H, Meamar AR, et al. Emerging Intestinal Microsporidia Infection in HIV(+)/AIDS Patients in Iran: Microscopic and Molecular Detection. Iran J Parasitol 2014; 9: 149-154.

Ghorbanzadeh B, Sadraie J, Emadi Kuchak H. Diagnosis of Cryptosporidium and intestinal Microsporidia in HIV/AIDS patients with staining and PCR methods on 16srRNA gen. AMUJ 2012; 15: 37-47.

Khalili B, Imani R, Boostani S. Intestinal Parasitic Infections in Chronic Psychiatric Patients in Sina Hospital Shahre-Kord, Iran. Jundishapur J Microbiol 2013; 6: 252-255.

IssueVol 9 No 3 (2017) QRcode
SectionReview Article(s)
Epidemiology Public health Infectious diseases Plague Tuberculosis Dengue

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Parhizgari N, Gouya MM, Mostafavi E. Emerging and re-emerging infectious diseases in Iran. Iran J Microbiol. 2017;9(3):122-142.